Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer-Reply.

Wang, Zhijie

Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer-Reply. [electronic resource] - JAMA oncology 07 2020 - 1116-1117 p. digital

Publication Type: Letter; Comment

2374-2445

10.1001/jamaoncol.2020.0646 doi


Apoptosis
B7-H1 Antigen
Humans
Immune Checkpoint Inhibitors
Immunotherapy
Ligands
Neoplasms--drug therapy